9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding 9 Meters Biopharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 88 | −12 |
| Shares | 75.6M | 36.9K | 58.4M | −17.2M (−22.7%) |
| Value | $45.2M | $22.0K | $15.2M | −$30.0M (−66.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 4,553,084 | $1.19M | 0.05% |
| Millennium Management LLC | 1,850,825 | $483.0K | 0.00% |
| Ergoteles LLC | 996,200 | $260.0K | 0.01% |
| Qube Research & Technologies Ltd | 287,807 | $75.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 184,315 | $48.0K | 0.01% |
| Virtu Financial LLC | 181,983 | $47.0K | 0.00% |
| LMR Partners LLP | 107,679 | $28.0K | 0.00% |
| Atom Investors LP | 102,338 | $27.0K | 0.01% |
| Boothbay Fund Management, LLC | 97,830 | $26.0K | 0.00% |
| Two Sigma Securities, LLC | 52,860 | $14.0K | 0.00% |
| SG Americas Securities, LLC | 30,187 | $8.00K | 0.00% |
| Merit Financial Group, LLC | 25,000 | $7.00K | 0.00% |
| Squarepoint Ops LLC | 10,713 | $3.00K | 0.00% |
| Captrust Financial Advisors | 3,344 | $1.00K | 0.00% |
| CoreCap Advisors, LLC | 2,010 | $1.00K | 0.00% |
| Credit Suisse AG | 566 | $0 | 0.00% |
| High Net Worth Advisory Group LLC | 1,000 | $0 | 0.00% |
Sold out (29)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (1)
Institutions that held 9 Meters Biopharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 36,861 | $22.0K |